Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AXGN · against 1,372 other Healthcare companies
Ranked #341 of 1,373 · scores higher than 75% of peers · safety percentile 75
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 70–79, including AXGN · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AXGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.08× | 0.24× | 70% | 33% | |
| BetaLower is better · 1,320 reported | 1.17 | 0.53 | 19% | 33% | |
| Current ratioHigher is better · 1,338 reported | 6.60× | 2.62× | 80% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 337 | 10.5B USD | 76 | 56 | |
| 338 | 1.1B USD | 75 | 46 | |
| 339 | 118.0B INR (≈$1.4B) | 75 | 68 | |
| 340 | 905M CHF (≈$1.0B) | 75 | 75 | |
| 341 | 2.9B USD | 75 | 44 | |
| 342 | 106M EUR (≈$116M) | 75 | 46 | |
| 343 | 117M USD | 75 | 40 | |
| 344 | 2.7B CNY (≈$373M) | 75 | 67 | |
| 345 | 179.7B INR (≈$2.2B) | 75 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score